Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report) shares dropped 7.9% on Thursday . The stock traded as low as $22.33 and last traded at $22.33. Approximately 204 shares changed hands during trading, an increase of 10% from the average daily volume of 186 shares. The stock had previously closed at $24.25.
Hikma Pharmaceuticals Stock Performance
The firm’s 50-day moving average price is $24.18 and its 200 day moving average price is $23.67. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.57 and a quick ratio of 0.90.
Hikma Pharmaceuticals Increases Dividend
The firm also recently declared a dividend, which will be paid on Friday, May 3rd. Stockholders of record on Friday, March 22nd will be given a $0.47 dividend. The ex-dividend date is Wednesday, March 20th. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.25.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- MarketBeat Week in Review – 4/15 – 4/19
- Want to Profit on the Downtrend? Downtrends, Explained.
- Comprehensive Analysis of PayPal Stock
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
